Our ECM practice guides clients through the complexities of equity capital raisings in the public and private capital markets, helping them navigate regulatory hurdles and seize market opportunities. With extensive experience representing issuers, investors, lead managers and underwriters, we advise on IPOs and secondary offerings, including private placements, security purchase plans and entitlement offers, as well as capital management strategies such as buy-backs, capital reductions, consolidations and splits.
Our team provides tailored, strategic insights and practical solutions to meet the different needs of issuers, investors and underwriters. We offer a proven track record in successful transactions, coupled with a deep understanding of market trends and regulatory requirements. From advice on regulatory issues, structuring and the preparation of disclosure documents to coordinating due diligence and managing compliance, we seek to ensure a seamless legal process which supports (rather than stifles) transactions. With strong expertise in dealing with ASIC and ASX, we also advise on relief applications to navigate complex regulatory issues.
Our strategic advice on market trends, regulatory changes and best practice helps clients remain competitive in dynamic environments, especially within the life sciences, healthcare, technology and energy & resources sectors.
Leveraging our experience and industry knowledge, we work with our clients to capitalise on opportunities and help them achieve their financial and strategic goals.
Work highlights
BCI Minerals Limited (ASX:BCI)
Fully-underwritten accelerated non-renounceable entitlement offer and placement, together with the simultaneous conversion of convertible notes into shares, to fund the equity component of the salt-first phase of its Mardie project.
CurveBeam AI Limited (ASX:CVB)
IPO and ASX listing and its accelerated non-renounceable entitlement offer and two tranche placement.
Novo Resources Corp (ASX:NVO, TSX: NVO)
Oversubscribed IPO and listing of its CHESS Depositary Interests (CDIs) on the ASX.
EBR Systems, Inc (AXS:EBR)
Capital raise, private placement and security purchase plan of CDIs and IPO and ASX listing.
Imricor Medical Systems. Inc. (ASX:IMR)
Pre-IPO convertible note offering, IPO and ASX listing and various other equity raisings including its accelerated non-renounceable entitlement offer and two tranche placement.
Arafura Rare Earths (ASX:ARU)
Various equity raisings, including accelerated entitlement offers, share purchase plans and placements of shares and options, to fund the ongoing development of its Nolans rare earths project.
